Biora Therapeutics Inc (PK) (BIOR) ニュース

Form 8-K - Current report

BioDrain Medical to Present at the Second Annual Marcum LLP MicroCap Conference

BioDrain Medical to Present at the Second Annual Marcum LLP MicroCap Conference PR Newswire MINNEAPOLIS, May 23, 2013 MINNEAPOLIS...

- Current report filing (8-K)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549     FORM 8-K     CURRENT...

- Amended Quarterly Report (10-Q/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   FORM 10-Q/A   x QUARTERLY REPORT PURSUANT TO SECTION...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Amended Statement of Beneficial Ownership (SC 13D/A)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D   Under the Securities Exchange...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Amended Statement of Beneficial Ownership (SC 13D/A)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D   Under the Securities Exchange...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Initial Statement of Beneficial Ownership (3)

FORM 3          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

- Initial Statement of Beneficial Ownership (3)

FORM 3          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

- Quarterly Report (10-Q)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   FORM 10-Q   x QUARTERLY REPORT PURSUANT TO...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549     FORM 8-K     CURRENT REPORT...

BioDrain Medical Inc. Signs Additional Independent Distribution Agreements, Strengthening Nationwide Presence

BioDrain Medical Inc. Signs Additional Independent Distribution Agreements, Strengthening Nationwide Presence PR Newswire MINNEAPOLIS, July 20...